Deep Research Protocol Initiated
Scanning CT.gov | OpenFDA | PubMed | NIH Reporter | CMS | CDC | NPI | Census | FCC
Status
Phase
Country
Expert Query (CT.gov syntax)
Detail Limit
Trial Row Limit
Require Contact
Min Sites w/ Contact
LIVE FEED
Connecting to global clinical registry stream...
GLOBAL RECRUITMENT
-
Active Recruiting Studies
SOURCE: ClinicalTrials.gov
TOP THERAPEUTIC AREAS
  • Oncology-
  • Neurology-
  • Cardiology-
  • AI ScoringActive
PHASE DISTRIBUTION
0
Trials Found
0
Recruiting
0
Publications
0
Active Grants
0%
Prime Site Rate
0%
Contact Rate
Metric Details Formulas and interpretation
Clinical Trials
Analytics & Map
Site Hunter
Intelligence Hub
Operations Risk
Decision Desk
Patient Finder
Site 360
Forecast
Methodology
RWE & Safety
Literature
Funding
Operational signals only: scores and tiers are model-derived estimates from public-source metadata, not determinations of clinical quality, misconduct, or legal/compliance status. Verify with source records and local review before decisions.
Ready to search...
Trial Details Phase Status Risk Velocity Sites Contacts
Prime (80+) Viable (50-79) Standard (<50) Score formula: 50 recruiting + 30 contact + 10 named contact + 10 geocoded

Executive Summary

SITE CAPACITY & PATIENT ACCESS DISCOVERY
Aggregating 0 sites with inferred capacity, execution history, and contact readiness
Facility Name Location Capacity Tier Capacity Score Active / Total Avg Velocity Experience Risk Studies / Investigators Contact Coverage Contact
CLINICAL OPERATIONS INTELLIGENCE HUB
Unified evidence for clinicians, principal investigators, and study operations teams.
Investigator Network Strength
InvestigatorRoleInfluenceTrialsActiveAvg Velocity
Funding Concentration (NIH)
OrganizationTotal Award (USD)
Evidence Momentum (OpenAlex)
Country Readiness Context
CountryTrialsPopulationHealth Spend/CapitaPhysicians/1000
Public Data Signal Stack (NPI / CMS / CDC)
CMS + CDC Prioritization Rows
StateCDC BurdenCMS MatchesNPI MatchesPriority
PHASE 3: STARTUP & RETENTION RISK INTELLIGENCE
Quantifies startup readiness, patient retention risk, and execution confidence for each active trial candidate.
TrialTierStartupRetention RiskExecutionDriversMitigation
PHASE 4: CLINICIAN DECISION DESK
Connects site activation, patient access pathways, and sponsor-fit scoring into a single action workflow.
Activation Targets
Mitigation Priority Queue
Sponsor Fit Ranking
SponsorFitClassTrialsActiveStartupRiskContact
Patient Access Pathways
ConditionPriorityCountriesChannels
Patient Finder Plan (Who, Where, How)
Recommended Next Actions
PATIENT FINDER WORKBENCH
Operational patient acquisition plan by condition: who to target, where to recruit, how to activate channels, and which sites have direct contacts.
Who / Where / How Plans
Pathway Priority Matrix
ConditionPriorityCountriesChannels
ZIP/County Patient Opportunity (Public Data)
ZIP / CountyOpportunityActive TrialsSite DensityBurdenAccess BarrierConfidence
SITE 360 PROFILE WORKBENCH
Unified site-level capacity, risk, investigator, study, and patient-access profile with explicit recommendation tier.
SiteLocationCapacityRiskPatient AccessExternal EvidenceActive / TotalInvestigatorsTop ConditionsHistoryAction
RECRUITMENT FORECAST ENGINE
Condition-level demand versus supply gap model to prioritize patient recruitment execution and channel investments.
ConditionPriorityGapDemandSupplyActive TrialsAvg EnrollmentCountriesChannelsTop Sites
METRIC DEFINITIONS & CALCULATION LOGIC
Every score includes formula, interpretation, sample size, and source provenance so clinicians can trust what they are seeing.
Methodology Detail Table
MetricFormulaInterpretationSample SizeSources / Refresh

Real-World Evidence (OpenFDA FAERS)

PATIENT DEMOGRAPHICS (SEX)
TOP REPORTED REACTIONS

Approved Therapies

TitleAuthorsSourceDate
ProjectPIOrganizationAmountPeriod